TPST
Tempest Therapeutics Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Tempest Therapeutics specializes in cancer treatments through innovative approaches targeting the immune system.
Tempest Therapeutics Inc
TPST
Tempest Therapeutics specializes in cancer treatments through innovative approaches targeting the immune system.
Price history of Tempest Therapeutics Inc
Price history of Tempest Therapeutics Inc
Performance & Momentum
Strategic Analysis
Tempest Therapeutics Inc • 2026
Tempest Therapeutics positions itself in the innovative field of oncology biotechnology by developing treatments that target the immune system to fight cancer. Its differentiation is based on disruptive therapeutic approaches centered around immuno-oncology, with significant value creation potential in the event of clinical success.
- Focus on immuno-oncology, a rapidly growing field with high medical need
- Innovative technologies targeting differentiating mechanisms of action
- Scientific expertise in immune modulation applied to cancer
- Fragile financial situation linked to significant losses and the lack of marketed products
- Severely degraded stock performance over the long term, impacting investor confidence
The momentum is very weak with a prolonged downward trend across all observed periods, reflecting limited market confidence in the short and medium term. The absence of recent news reinforces this sentiment, highlighting the need for clinical or strategic catalysts to reverse the trend.
Similar stocks to Tempest Therapeutics Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
